observed a decrease of 50% in naive CD4 T cells (CCR7+CD45RO-) and a corresponding 34% rise in central memory CD4 T cells (CCR7+CD45RO+) among CKD stage 5 patients as compared to healthy individuals. This evidence concerns the gene CD4 and chronic kidney disease.